Founded in 2019, Ronovo Surgical is accelerating the transition to truly intelligent MIS through innovative robotic and digital solutions. It is the only soft tissue robotic surgery company in China led by seasoned industry leaders with expertise in both commercial leadership and technology development.
Founder and CEO John Ma is former SVP at Intuitive and Global Partner at Fosun Group. Co-Founder and CTO Ying Mao is former systems engineering lead at Auris Health (now J&J Ethicon) and founder of Dreamworld AR. With more than two decades of leadership experience combined specifically in the development and commercialization of surgical robotics systems, they now lead a seasoned core team that represents deep product development and implementation expertise in surgical robotics, industrial robotics, medical capital equipment, and medical consumables from Chinese and multinational manufacturers. Additionally, Ronovo has significant global clinical and technical resources, having established long-term partnerships with numerous clinical and technical advisors.
Ronovo’s inaugural robotic platform – Carina™, is an innovative modular system built on proprietary technology to enable configurable robotic assistance for laparoscopic surgeries across multiple specialties.
Developed in collaboration with renowned Chinese laparoscopic surgeons, Carina addresses numerous pain points in minimally invasive surgeries (MIS) with a modular and nimble robotic solution. The system provides surgeons flexibility to choose the best instruments and the most ideal anatomical access based on laparoscopy foundation. In this way, surgeons can leverage – rather than abandon – prior laparoscopic training and continue to improve upon their surgical performance, allowing for MIS in more surgical specialties to be performed robotically.
* The Carina™ system is currently in development and has not been commercialized.
